Neurones (France) Top Management
NRO Stock | EUR 44.90 0.05 0.11% |
Neurones employs about 6 K people. The company is managed by 4 executives with a total tenure of roughly 16 years, averaging almost 4.0 years of service per executive, having 1490.25 employees per reported executive. Analysis of Neurones' management performance can provide insight into the company performance.
Luc Chammard Chairman Chairman, CEO and Associate Director |
Neurones |
Neurones Management Team Effectiveness
The company has return on total asset (ROA) of 0.077 % which means that it generated a profit of $0.077 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1403 %, meaning that it generated $0.1403 on every $100 dollars invested by stockholders. Neurones' management efficiency ratios could be used to measure how well Neurones manages its routine affairs as well as how well it operates its assets and liabilities.Neurones Workforce Comparison
Neurones is considered to be number one stock in number of employees category among its peers. The total workforce of Information Technology industry is now estimated at about 15,942. Neurones totals roughly 5,961 in number of employees claiming about 37% of equities under Information Technology industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11. Neurones Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Neurones Price Series Summation is a cross summation of Neurones price series and its benchmark/peer.
Neurones Notable Stakeholders
A Neurones stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Neurones often face trade-offs trying to please all of them. Neurones' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Neurones' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Luc Chammard | Chairman, CEO and Associate Director | Profile | |
Bertrand Ducurtil | COO, Executive VP, Deputy Managing Director, Associate Director and Director | Profile | |
Matthieu Vautier | Chief Officer | Profile | |
PaulCsar Bonnel | Adm director | Profile |
About Neurones Management Performance
The success or failure of an entity such as Neurones often depends on how effective the management is. Neurones management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neurones management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neurones management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. It employs 5160 people.
Please note, the presentation of Neurones' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Neurones' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Neurones' management manipulating its earnings.
Neurones Workforce Analysis
Traditionally, organizations such as Neurones use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Neurones within its industry.Neurones Manpower Efficiency
Return on Neurones Manpower
Revenue Per Employee | 97.3K | |
Revenue Per Executive | 145M | |
Net Income Per Employee | 6.3K | |
Net Income Per Executive | 9.4M | |
Working Capital Per Employee | 25.3K | |
Working Capital Per Executive | 37.8M |
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
Commodity Directory Find actively traded commodities issued by global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
CEOs Directory Screen CEOs from public companies around the world |